Ra Capital Management, LLC

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
Yesterday 7:37 PM
View: 
Ars Pharmaceuticals, Inc. (SPRY) Yesterday Purchase 505,954$9.79$4,953,290.005%
10.36M to 10.86M
Yesterday 7:37 PM
View: 
Ars Pharmaceuticals, Inc. (SPRY) 26-Mar-24Purchase 457,745$9.55$4,371,460.005%
9.9M to 10.36M
Yesterday 7:37 PM
View: 
Ars Pharmaceuticals, Inc. (SPRY) 25-Mar-24Purchase 437,600$9.06$3,964,660.005%
9.46M to 9.9M
25-Mar-24 8:48 PM
View: 
Lenz Therapeutics, Inc. (LENZ) 21-Mar-24Grant 3,245,780----515%
629.79K to 3.88M
25-Mar-24 8:48 PM
View: 
Lenz Therapeutics, Inc. (LENZ) 21-Mar-24Purchase 998,009$15.03$15,000,100.0026%
3.88M to 4.87M
06-Mar-24 10:00 PM
View: 
89bio, Inc. (ETNB) 04-Mar-24Purchase 1,350,000$15.35$20,722,500.0012%
11.42M to 12.77M
20-Feb-24 8:07 PM
View: 
Icosavax, Inc. (ICVX) 19-Feb-24Disposition (change in control) 5,969,110----(100%)
5.97M to 0
14-Feb-24 7:49 PM
View: 
Mineralys Therapeutics, Inc. (MLYS) 12-Feb-24Grant 1,672,510$13.50$22,578,900.0053%
3.18M to 4.85M
5%
13-Feb-24 4:33 PM
View: 
Pepgen Inc. (PEPG) 09-Feb-24Purchase 2,557,590$10.64$27,212,800.0031%
8.13M to 10.69M
08-Feb-24 5:16 PM
View: 
Tyra Biosciences, Inc. (TYRA) 06-Feb-24Grant 3,180,160$13.01$41,373,800.0044%
7.24M to 10.42M
(6%)
12-Jan-24 5:01 PM
View: 
Solid Biosciences Inc. (SLDB) 11-Jan-24Purchase 904,160$5.53$5,000,000.0027%
3.4M to 4.3M
13-Dec-23 4:33 PM
View: 
Wave Life Sciences Ltd. (WVE) 11-Dec-23Purchase 1,000,000$5.00$5,000,000.005%
18.2M to 19.2M
25-Sep-23 4:30 PM
View: 
Ars Pharmaceuticals, Inc. (SPRY) 21-Sep-23Private Purchase 2,700,000$3.03$8,183,530.0018%
15.13M to 17.83M
31-Aug-23 5:26 PM
View: 
Ars Pharmaceuticals, Inc. (SPRY) 29-Aug-23Purchase 3,750,000$6.20$23,250,000.00125%
3.01M to 6.76M
22-Aug-23 5:01 PM
View: 
An2 Therapeutics, Inc. (ANTX) 18-Aug-23Private Purchase 1,777,780$9.00$16,000,000.0047%
3.77M to 5.55M
09-Aug-23 5:00 PM
View: 
Dice Therapeutics, Inc. (DICE) 09-Aug-23Disposition (change in control) 7,856,610----(100%)
7.86M to 0
25-Jul-23 4:30 PM
View: 
Acumen Pharmaceuticals, Inc. (ABOS) 21-Jul-23Purchase 5,161,290$7.75$40,000,000.0053%
9.77M to 14.93M
21-Jul-23 4:31 PM
View: 
Janux Therapeutics, Inc. (JANX) 19-Jul-23Private Purchase 495,008$12.46$6,167,800.006%
8.67M to 9.17M
07-Jul-23 4:30 PM
View: 
Black Diamond Therapeutics,... (BDTX) 05-Jul-23Market Purchase 935,850$5.00$4,679,250.0036%
2.59M to 3.53M
(10%)
12-Jun-23 8:23 PM
View: 
Satsuma Pharmaceuticals, Inc. (STSA) 08-Jun-23Disposition (change in control) 5,914,250----(100%)
5.91M to 0
30-Mar-23 5:03 PM
View: 
Dice Therapeutics, Inc. (DICE) 30-Mar-23Purchase 195,997$28.74$5,632,950.00< 1%
21.34M to 21.54M
30-Mar-23 5:03 PM
View: 
Dice Therapeutics, Inc. (DICE) 29-Mar-23Purchase 66,369$29.38$1,949,920.00< 1%
21.28M to 21.34M
30-Mar-23 5:03 PM
View: 
Dice Therapeutics, Inc. (DICE) 28-Mar-23Purchase 246,779$29.24$7,215,820.001%
21.03M to 21.28M
27-Mar-23 5:01 PM
View: 
Dice Therapeutics, Inc. (DICE) 27-Mar-23Purchase 151,132$27.48$4,153,110.00< 1%
19.82M to 19.98M
27-Mar-23 5:01 PM
View: 
Dice Therapeutics, Inc. (DICE) 24-Mar-23Purchase 192,335$26.87$5,168,040.00< 1%
19.63M to 19.82M
30-Mar-23 5:00 PM
View: 
89bio, Inc. (ETNB) 24-Mar-23Purchase 2,461,540$16.25$40,000,000.0027%
8.96M to 11.42M
27-Mar-23 5:01 PM
View: 
Dice Therapeutics, Inc. (DICE) 23-Mar-23Purchase 155,089$26.67$4,136,220.00< 1%
19.48M to 19.63M
27-Feb-23 4:31 PM
View: 
Enliven Therapeutics, Inc. (ELVN) 23-Feb-23Grant 1,152,460----119%
970.0K to 2.12M
16-Feb-23 5:04 PM
View: 
Mineralys Therapeutics, Inc. (MLYS) 14-Feb-23Conversion 1,928,480----100%
0 to 1.93M
16-Feb-23 5:04 PM
View: 
Mineralys Therapeutics, Inc. (MLYS) 14-Feb-23Private Purchase 1,250,000$16.00$20,000,000.0065%
1.93M to 3.18M
24-Jan-23 4:30 PM
View: 
Fulcrum Therapeutics, Inc. (FULC) 20-Jan-23Private Purchase 1,923,080$13.00$25,000,000.0020%
9.69M to 11.61M
10-Jan-23 5:14 PM
View: 
Werewolf Therapeutics, Inc. (HOWL) 06-Jan-23Private Purchase 1,853,000$2.21$4,095,130.0043%
4.29M to 6.14M
06-Jan-23 4:39 PM
View: 
Fulcrum Therapeutics, Inc. (FULC) 04-Jan-23Private Purchase 180,703$7.28$1,314,810.00< 1%
19.13M to 19.31M
05-Jan-23 4:43 PM
View: 
Enliven Therapeutics, Inc. (ELVN) 03-Jan-23Purchase 629,297$4.00$2,516,060.0019%
3.25M to 3.88M
29-Dec-22 5:00 PM
View: 
Fulcrum Therapeutics, Inc. (FULC) 27-Dec-22Private Purchase 4,089$5.99$24,509.90< 1%
9.5M to 9.51M
21-Dec-22 4:30 PM
View: 
Fulcrum Therapeutics, Inc. (FULC) 19-Dec-22Private Purchase 98,787$5.90$582,814.001%
9.4M to 9.5M
16-Dec-22 4:41 PM
View: 
Fulcrum Therapeutics, Inc. (FULC) 16-Dec-22Purchase 1,341,420$5.42$7,269,830.006%
23.95M to 25.29M
16-Dec-22 4:41 PM
View: 
Fulcrum Therapeutics, Inc. (FULC) 15-Dec-22Purchase 237,029$5.49$1,302,470.00< 1%
23.71M to 23.95M
16-Dec-22 4:41 PM
View: 
Fulcrum Therapeutics, Inc. (FULC) 14-Dec-22Private Purchase 824,600$5.46$4,501,570.004%
22.89M to 23.71M
12-Dec-22 4:30 PM
View: 
Enliven Therapeutics, Inc. (ELVN) 09-Dec-22Purchase 19,299$3.93$75,845.10< 1%
6.46M to 6.48M
09-Dec-22 4:32 PM
View: 
Vor Biopharma Inc. (VOR) 09-Dec-22Grant 11,627,900$4.30$50,000,000.00105%
11.12M to 22.75M
12-Dec-22 4:30 PM
View: 
Enliven Therapeutics, Inc. (ELVN) 08-Dec-22Purchase 10,600$3.75$39,750.00< 1%
6.45M to 6.46M
05-Dec-22 5:02 PM
View: 
Solid Biosciences Inc. (SLDB) 02-Dec-22Grant 2,573,190$5.93$15,250,000.00312%
824.53K to 3.4M
21-Nov-22 4:31 PM
View: 
Acrivon Therapeutics, Inc. (ACRV) 17-Nov-22Conversion 1,421,010----100%
0 to 1.42M
21-Nov-22 4:31 PM
View: 
Acrivon Therapeutics, Inc. (ACRV) 17-Nov-22Private Purchase 3,389,500$12.50$42,368,800.00239%
1.42M to 4.81M
10-Nov-22 6:00 PM
View: 
Ars Pharmaceuticals, Inc. (SPRY) 08-Nov-22Grant 3,009,680----100%
0 to 3.01M
24-Oct-22 4:41 PM
View: 
Enliven Therapeutics, Inc. (ELVN) 24-Oct-22Purchase 26,460$3.91$103,459.00< 1%
9.54M to 9.56M
24-Oct-22 4:41 PM
View: 
Enliven Therapeutics, Inc. (ELVN) 21-Oct-22Purchase 48,100$3.92$188,552.00< 1%
9.49M to 9.54M
24-Oct-22 4:41 PM
View: 
Enliven Therapeutics, Inc. (ELVN) 20-Oct-22Purchase 11,342$3.95$44,800.90< 1%
9.48M to 9.49M
19-Oct-22 4:40 PM
View: 
Enliven Therapeutics, Inc. (ELVN) 19-Oct-22Purchase 125,726$3.89$488,659.001%
8.79M to 8.92M